Cargando…

Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype

BACKGROUND: The molecular mechanisms underlying the association between increased adiposity and aggressive breast cancer phenotypes remain unclear, but likely involve the adipokines, leptin (LEP) and adiponectin (ADIPOQ), and their receptors (LEPR, ADIPOR1, ADIPOR2). METHODS: We used immunohistochem...

Descripción completa

Detalles Bibliográficos
Autores principales: Llanos, Adana A. M., Lin, Yong, Chen, Wenjin, Yao, Song, Norin, Jorden, Chekmareva, Marina A., Omene, Coral, Cong, Lei, Omilian, Angela R., Khoury, Thaer, Hong, Chi-Chen, Ganesan, Shridar, Foran, David J., Higgins, Michael, Ambrosone, Christine B., Bandera, Elisa V., Demissie, Kitaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014630/
https://www.ncbi.nlm.nih.gov/pubmed/32046756
http://dx.doi.org/10.1186/s13058-020-1256-3
_version_ 1783496673679376384
author Llanos, Adana A. M.
Lin, Yong
Chen, Wenjin
Yao, Song
Norin, Jorden
Chekmareva, Marina A.
Omene, Coral
Cong, Lei
Omilian, Angela R.
Khoury, Thaer
Hong, Chi-Chen
Ganesan, Shridar
Foran, David J.
Higgins, Michael
Ambrosone, Christine B.
Bandera, Elisa V.
Demissie, Kitaw
author_facet Llanos, Adana A. M.
Lin, Yong
Chen, Wenjin
Yao, Song
Norin, Jorden
Chekmareva, Marina A.
Omene, Coral
Cong, Lei
Omilian, Angela R.
Khoury, Thaer
Hong, Chi-Chen
Ganesan, Shridar
Foran, David J.
Higgins, Michael
Ambrosone, Christine B.
Bandera, Elisa V.
Demissie, Kitaw
author_sort Llanos, Adana A. M.
collection PubMed
description BACKGROUND: The molecular mechanisms underlying the association between increased adiposity and aggressive breast cancer phenotypes remain unclear, but likely involve the adipokines, leptin (LEP) and adiponectin (ADIPOQ), and their receptors (LEPR, ADIPOR1, ADIPOR2). METHODS: We used immunohistochemistry (IHC) to assess LEP, LEPR, ADIPOQ, ADIPOR1, and ADIPOR2 expression in breast tumor tissue microarrays among a sample of 720 women recently diagnosed with breast cancer (540 of whom self-identified as Black). We scored IHC expression quantitatively, using digital pathology analysis. We abstracted data on tumor grade, tumor size, tumor stage, lymph node status, Ki67, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) from pathology records, and used ER, PR, and HER2 expression data to classify breast cancer subtype. We used multivariable mixed effects models to estimate associations of IHC expression with tumor clinicopathology, in the overall sample and separately among Blacks. RESULTS: Larger proportions of Black than White women were overweight or obese and had more aggressive tumor features. Older age, Black race, postmenopausal status, and higher body mass index were associated with higher LEPR IHC expression. In multivariable models, lower LEPR IHC expression was associated with ER-negative status and triple-negative subtype (P < 0.0001) in the overall sample and among Black women only. LEP, ADIPOQ, ADIPOR1, and ADIPOR2 IHC expression were not significantly associated with breast tumor clinicopathology. CONCLUSIONS: Lower LEPR IHC expression within the breast tumor microenvironment might contribute mechanistically to inter-individual variation in aggressive breast cancer clinicopathology, particularly ER-negative status and triple-negative subtype.
format Online
Article
Text
id pubmed-7014630
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70146302020-02-18 Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype Llanos, Adana A. M. Lin, Yong Chen, Wenjin Yao, Song Norin, Jorden Chekmareva, Marina A. Omene, Coral Cong, Lei Omilian, Angela R. Khoury, Thaer Hong, Chi-Chen Ganesan, Shridar Foran, David J. Higgins, Michael Ambrosone, Christine B. Bandera, Elisa V. Demissie, Kitaw Breast Cancer Res Research Article BACKGROUND: The molecular mechanisms underlying the association between increased adiposity and aggressive breast cancer phenotypes remain unclear, but likely involve the adipokines, leptin (LEP) and adiponectin (ADIPOQ), and their receptors (LEPR, ADIPOR1, ADIPOR2). METHODS: We used immunohistochemistry (IHC) to assess LEP, LEPR, ADIPOQ, ADIPOR1, and ADIPOR2 expression in breast tumor tissue microarrays among a sample of 720 women recently diagnosed with breast cancer (540 of whom self-identified as Black). We scored IHC expression quantitatively, using digital pathology analysis. We abstracted data on tumor grade, tumor size, tumor stage, lymph node status, Ki67, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) from pathology records, and used ER, PR, and HER2 expression data to classify breast cancer subtype. We used multivariable mixed effects models to estimate associations of IHC expression with tumor clinicopathology, in the overall sample and separately among Blacks. RESULTS: Larger proportions of Black than White women were overweight or obese and had more aggressive tumor features. Older age, Black race, postmenopausal status, and higher body mass index were associated with higher LEPR IHC expression. In multivariable models, lower LEPR IHC expression was associated with ER-negative status and triple-negative subtype (P < 0.0001) in the overall sample and among Black women only. LEP, ADIPOQ, ADIPOR1, and ADIPOR2 IHC expression were not significantly associated with breast tumor clinicopathology. CONCLUSIONS: Lower LEPR IHC expression within the breast tumor microenvironment might contribute mechanistically to inter-individual variation in aggressive breast cancer clinicopathology, particularly ER-negative status and triple-negative subtype. BioMed Central 2020-02-11 2020 /pmc/articles/PMC7014630/ /pubmed/32046756 http://dx.doi.org/10.1186/s13058-020-1256-3 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Llanos, Adana A. M.
Lin, Yong
Chen, Wenjin
Yao, Song
Norin, Jorden
Chekmareva, Marina A.
Omene, Coral
Cong, Lei
Omilian, Angela R.
Khoury, Thaer
Hong, Chi-Chen
Ganesan, Shridar
Foran, David J.
Higgins, Michael
Ambrosone, Christine B.
Bandera, Elisa V.
Demissie, Kitaw
Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title_full Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title_fullStr Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title_full_unstemmed Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title_short Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
title_sort immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014630/
https://www.ncbi.nlm.nih.gov/pubmed/32046756
http://dx.doi.org/10.1186/s13058-020-1256-3
work_keys_str_mv AT llanosadanaam immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT linyong immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT chenwenjin immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT yaosong immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT norinjorden immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT chekmarevamarinaa immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT omenecoral immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT conglei immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT omilianangelar immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT khourythaer immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT hongchichen immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT ganesanshridar immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT forandavidj immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT higginsmichael immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT ambrosonechristineb immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT banderaelisav immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype
AT demissiekitaw immunohistochemicalanalysisofadipokineandadipokinereceptorexpressioninthebreasttumormicroenvironmentassociationsoflowerleptinreceptorexpressionwithestrogenreceptornegativestatusandtriplenegativesubtype